These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
226 related articles for article (PubMed ID: 25217152)
1. Diagnostic and prognostic role of peritoneal CA 125 in peritoneal dialysis patients presenting with acute peritonitis. Panorchan K; Davenport A BMC Nephrol; 2014 Sep; 15():149. PubMed ID: 25217152 [TBL] [Abstract][Full Text] [Related]
2. Peritoneal dialysate effluent and serum CA125 concentrations in stable peritoneal dialysis patients. Redahan L; Davenport A J Nephrol; 2016 Jun; 29(3):427-434. PubMed ID: 26616639 [TBL] [Abstract][Full Text] [Related]
3. Dialysate cancer antigen 125 concentration as marker of peritoneal membrane status in patients treated with chronic peritoneal dialysis. Krediet RT Perit Dial Int; 2001; 21(6):560-7. PubMed ID: 11783764 [TBL] [Abstract][Full Text] [Related]
4. Expression of cancer antigen 125 by peritoneal mesothelial cells is not influenced by duration of peritoneal dialysis. Sanusi AA; Zweers MM; Weening JJ; de Waart DR; Struijk DG; Krediet RT Perit Dial Int; 2001; 21(5):495-500. PubMed ID: 11757834 [TBL] [Abstract][Full Text] [Related]
5. Effects of Icodextrin and Glucose Bicarbonate/Lactate-Buffered Peritoneal Dialysis Fluids on Effluent Cell Population and Biocompatibility Markers IL-6 and CA125 in Incident Peritoneal Dialysis Patients. Opatrná S; Pöpperlová A; Lysák D; Fuchsová R; Trefil L; Racek J; Topolčan O Ther Apher Dial; 2016 Apr; 20(2):149-57. PubMed ID: 26929256 [TBL] [Abstract][Full Text] [Related]
6. The alteration of dialysate cancer antigen 125 concentration under a biocompatible bicarbonate peritoneal dialysis solution and the preservation of the mesothelial cell viability. Theodoridis M; Passadakis P; Kriki P; Gioka T; Panagoutsos S; Mourvati E; Thodis E; Kantartzi K; Vargemezis V Ren Fail; 2008; 30(2):161-7. PubMed ID: 18300115 [TBL] [Abstract][Full Text] [Related]
7. Dialysate CA125 levels in children on continuous peritoneal dialysis. Turhan P; Sever L; Caliskan S; Kasapcopur O; Sever A; Hacibekiroglu M; Arisoy N Pediatr Nephrol; 2005 Nov; 20(11):1615-21. PubMed ID: 16133054 [TBL] [Abstract][Full Text] [Related]
8. The Role of NGAL in Peritoneal Dialysis Effluent in Early Diagnosis of Peritonitis: Case-Control Study in Peritoneal Dialysis Patients. Martino F; Scalzotto E; Giavarina D; Rodighiero MP; Crepaldi C; Day S; Ronco C Perit Dial Int; 2015; 35(5):559-65. PubMed ID: 25395499 [TBL] [Abstract][Full Text] [Related]
10. Dialysate markers of peritoneal tissue during peritonitis and in stable CAPD. Pannekeet MM; Zemel D; Koomen GC; Struijk DG; Krediet RT Perit Dial Int; 1995; 15(6):217-25. PubMed ID: 7578497 [TBL] [Abstract][Full Text] [Related]
11. Peritoneal kinetics of cancer antigen 125 in peritoneal dialysis patients: the relationship with peritoneal outcome. Jiménez C; Díaz C; Selgas R; Auxiliadora Bajo M; del Peso G; Sánchez-Tomero JA; Gonzalez-Gancedo P Adv Perit Dial; 1999; 15():36-9. PubMed ID: 10682069 [TBL] [Abstract][Full Text] [Related]
12. Peritoneal effluent markers of inflammation in patients treated with icodextrin-based and glucose-based dialysis solutions. Parikova A; Zweers MM; Struijk DG; Krediet RT Adv Perit Dial; 2003; 19():186-90. PubMed ID: 14763059 [TBL] [Abstract][Full Text] [Related]
13. Determinants of peritoneal solute transport rates in newly started nondiabetic peritoneal dialysis patients. van Esch S; Zweers MM; Jansen MA; de Waart DR; van Manen JG; Krediet RT Perit Dial Int; 2004; 24(6):554-61. PubMed ID: 15559485 [TBL] [Abstract][Full Text] [Related]
14. Neutrophil gelatinase-associated lipocalin in peritoneal dialysis reflects status of peritoneum. Lacquaniti A; Chirico V; Mondello S; Buemi A; Lupica R; Fazio MR; Buemi M; Aloisi C J Nephrol; 2013; 26(6):1151-9. PubMed ID: 23807648 [TBL] [Abstract][Full Text] [Related]
15. Variability of effluent cancer antigen 125 and interleukin-6 determination in peritoneal dialysis patients. Lopes Barreto D; Coester AM; Noordzij M; Smit W; Struijk DG; Rogers S; de Waart DR; Krediet RT Nephrol Dial Transplant; 2011 Nov; 26(11):3739-44. PubMed ID: 21498425 [TBL] [Abstract][Full Text] [Related]
16. The Association of Effluent Ca125 with Peritoneal Dialysis Technique Failure. Barreto DL; Hoekstra T; Halbesma N; Leegte M; Boeschoten EW; Dekker FW; Krediet RT; Perit Dial Int; 2015 Dec; 35(7):683-90. PubMed ID: 26152581 [TBL] [Abstract][Full Text] [Related]
17. Dialysate cell population and cancer antigen 125 in stable continuous ambulatory peritoneal dialysis patients: their relationship with transport parameters. Lai KN; Lai KB; Szeto CC; Ho KK; Poon P; Lam CW; Leung JC Am J Kidney Dis; 1997 May; 29(5):699-705. PubMed ID: 9159303 [TBL] [Abstract][Full Text] [Related]
18. Short- and medium-term increase of CA125 in peritoneal effluent using a neutral-pH solution. García H; Hernández-Jaras J; Cruz Mdel C; Agramunt I; Calvo C; Cerrillo V Perit Dial Int; 2003; 23(4):375-80. PubMed ID: 12968846 [TBL] [Abstract][Full Text] [Related]
19. The association between the vascular endothelial growth factor-to-cancer antigen 125 ratio in peritoneal dialysis effluent and the epithelial-to-mesenchymal transition in continuous ambulatory peritoneal dialysis. Do JY; Kim YL; Park JW; Chang KA; Lee SH; Ryu DH; Kim CD; Park SH; Yoon KW Perit Dial Int; 2008 Jun; 28 Suppl 3():S101-6. PubMed ID: 18552237 [TBL] [Abstract][Full Text] [Related]
20. Assessment of the effectiveness, safety, and biocompatibility of icodextrin in automated peritoneal dialysis. The Dextrin in APD in Amsterdam (DIANA) Group. Posthuma N; ter Wee PM; Donker AJ; Oe PL; Peers EM; Verbrugh HA Perit Dial Int; 2000; 20 Suppl 2():S106-13. PubMed ID: 10911654 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]